Prohibits pharmacists from substituting anti-epileptic drugs without prescriber and patient consent.
New York Assembly Bill A05562 amends the public health and education laws to prohibit pharmacists from substituting any anti-epileptic drug for the prescribed drug without notifying the prescriber and obtaining the informed consent of the patient or their legal representative. This applies to all forms of anti-epileptic drugs, including brand and generic versions. The bill aims to ensure that patients receive the specific medication prescribed by their healthcare provider.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.